← Evidence map

ArticleCancer medicine2026

Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma.

Nora Mattila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Preoperative Biomarker Panel With Fibrinogen, FVIII, and CA 19-9 as a Tool for Prognostic Evaluation in Neoadjuvant-Treated Pancreatic Ductal Adenocarcinoma. | OpenQuestion